After a rough start to the year, small- and mid-cap software stocks may be finding their footing. Goldman Sachs analyst Adam ...

If approved by regulators, the acquisition would give Lilly strategic access to STC-004, an experimental non-opioid pain medication that is part of a class of drugs called Nav1.8 inhibitors.

Learn about Capex trends, data center growth, and how to invest in the infrastructure powering generative AI. Discover how hyperscaler capex is driving the future of cloud computing and AI.

Building on a longstanding partnership, the new MoU aims to deepen collaboration between HTX and Google Cloud in several ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Market Value and Growth In 2025, the Gene Therapy For Rare Disease Market Size is valued at approximately US$ 3.01 Billion in 2024, marking a substantial increase from previous years. This growth ...

The jewellery designer explores the possibilities of the baguette cut in a new collection, ‘Vertex’, a nod to art deco that ...

Google doubles down on its ‘world-model’ vision, racing to build an AI operating layer to drive a universal personal assistant with Gemini. Even as Microsoft moves to capture the enterprise UI. Here's ...

VIDEO: Vertex Minerals Ltd. Exec. Chairman Roger Jackson is interviewed by and outlines the Move to Gold Production for the Hill End project. Mr Jackson explains that the company is fully funded with ...

This leads to relatively smooth (though not flawless) northbound trajectories and strong returns for most stocks over a ...

Vertex Pharmaceuticals has solid revenue projections for its CF franchise, and a promising drug pipeline, especially in pain.

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...